- Bayer's Roundup Crisis Heats Up as It Braces for a 'Significant Surge' of New LawsuitsThe Roundup crisis has cost Bayer more than $30 billion in market value as the company lost three U.S. trials over whether the popular herbicide causes cancer.
- Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 BillionThe German company, which inherited Roundup from Monsanto, is facing 18,000 U.S. lawsuits over the weedkiller.
- Adidas Boss Warns Currency War Will Hurt More Than Tariffs"There is no winner in a currency war," said CEO Kasper Rorsted.
- Bayer Reports 5,000 More Roundup-Related Cancer Lawsuits“The jump in lawsuits is worrying,” an analyst said of the flood of litigation Bayer has inherited from Monsanto.
- Bayer Commits $5.6 Billion to Glyphosate Alternatives Amid 13,000 Lawsuits Over the WeedkillerThe move is seen as an olive branch to critics of the Roundup weedkiller, which is accused of causing cancer.
- Why Adidas Shares Are SoaringThe sports apparel maker is maintaining its half-decade hot streak.
- Bayer Gets Temporary Relief from Its Monsanto-Roundup WoesThe company faces mounting lawsuits alleging that Monsanto's Roundup weedkiller is linked to cancer.
Skip to Content